About

Science

Pipeline

Investor Information

Contact Us

Investor Information

Investor Information

Press Releases

Jun 10, 2014 7:00 AM EDT Can-Fite to Participate in Newport Coast Securities Conference in New York & ROTH Conference in London
Jun 9, 2014 7:00 AM EDT Can-Fite Subsidiary OphthaliX Provides an Update on its Clinical Developments and Strategic Plans
Jun 2, 2014 7:00 AM EDT Can-Fite Announces that the US FDA has Agreed with its Phase II Liver Cancer Protocol
May 30, 2014 4:32 PM EDT Can-Fite Announces 2014 Annual General Meeting
May 29, 2014 7:00 AM EDT Can-Fite Reports First Quarter 2014 Results
May 15, 2014 7:00 AM EDT Can-Fite to Exhibit at MIXiii Biomed Israel Innovation Conference
May 7, 2014 11:41 AM EDT Can-Fite Receives Patent in European Union for Treatment of Liver Function Following Surgery
Apr 29, 2014 7:00 AM EDT Can-Fite Submits Protocol to U.S. FDA for Phase II Liver Cancer Study
Apr 21, 2014 7:00 AM EDT Can-Fite Initiates the Development of an A3AR Biomarker Test Kit to Predict Patients' Response to Company's Drugs
Mar 31, 2014 2:28 PM EDT Can-Fite Files 2013 Annual Report on Form 20-F

Show All